Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis

NCT01125410 is registered in ClinicalTrials.gov with Medinova AG as lead sponsor.

NCT NCT01125410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01125410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis
Lead sponsor
Medinova AG
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
February 28, 2009
Enrollment
321 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis